IMPROVEMENTS OVER TIME WITH LONG-TERM VALBENAZINE IN OLDER AND ELDERLY PATIENTS WITH TARDIVE DYSKINESIA

被引：0
|
作者：
Sajatovic, Martha [2 ,3 ]
Alexopoulos, George [1 ]
Roque, Autumn [4 ]
Jen, Eric [4 ]
Lundt, Leslie [4 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Univ Hosp Clev, Cleveland, OH USA
[4] Neurocrine Biosci Inc, San Diego, CA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2023年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR-36
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [41] Effects of Long-Term Valbenazine on Tardive Dyskinesia and Patient-Reported Outcomes: Results from the KINECT 4 Study
    Singer, Carlos
    Comella, Cynthia
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    MOVEMENT DISORDERS, 2018, 33 : S19 - S19
  • [42] Low incidence of extrapyramidal symptoms in subjects with tardive dyskinesia receiving long-term valbenazine (NBI-98854) treatment
    Lessig, S.
    Kurlan, R.
    Factor, S.
    Burke, J.
    Wright, C.
    Jimenez, R.
    Liang, G.
    MOVEMENT DISORDERS, 2017, 32
  • [43] Efficacy of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia: Results of a Long-Term Study (KINECT 3 Extension)
    Factor, Stewart
    Comella, Cynthia
    Correll, Christoph
    Liang, Grace
    Burke, Joshua
    O'Brien, Christopher
    NEUROLOGY, 2017, 88
  • [44] Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia
    Goldberg, E.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Siegert, S.
    Angelov, A.
    MOVEMENT DISORDERS, 2020, 35 : S39 - S39
  • [45] REAL-WORLD EVALUATION OF PATIENT CHARACTERISTICS AND DISEASE MANAGEMENT IN LONG-TERM VALBENAZINE TREATMENT IN ADULTS WITH TARDIVE DYSKINESIA
    Siegert, S.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Dhanda, R.
    Farahmand, K.
    Lundt, L.
    Angelov, A.
    Goldberg, E.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E117 - E118
  • [46] The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder
    McIntyre, Roger S.
    Calabrese, Joseph R.
    Nierenberg, Andrew A.
    Farahmand, Khodayar
    Yonan, Chuck
    Siegert, Scott
    Burke, Joshua
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 246 : 217 - 223
  • [47] Tardive dyskinesia after long-term veralipride treatment
    Raja, M
    Azzoni, A
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 17 (02) : 252 - 253
  • [48] LONG-TERM TREATMENT OF TARDIVE-DYSKINESIA WITH LECITHIN
    BARTELS, M
    MEZGER, G
    SCHMALZING, G
    SCHONLE, PW
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1982, 32-2 (08): : 912 - 912
  • [49] LONG-TERM ALLEVIATION OF TARDIVE-DYSKINESIA WITH DIAZEPAM
    LAL, H
    SINGH, M
    BECKER, R
    NASRALLAH, H
    PITMAN, R
    DRUG DEVELOPMENT RESEARCH, 1982, 2 (05) : 502 - 502
  • [50] Treatment of long-term tardive dyskinesia with vitamin E
    Dorevitch, A
    Kalian, M
    Shlafman, M
    Lerner, V
    BIOLOGICAL PSYCHIATRY, 1997, 41 (01) : 114 - 116
12345